
Paras Healthcare IPO
Paras Healthcare is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar and Jharkhand among its peers, with an aggregate of 2,135 beds, as of March 31, 2024. The company has eight hospitals that it operates under the “Paras Health” brand, which are spread across five states and one union territory in North India –Gurugram and Panchkula in Haryana; Patna and Darbhanga in Bihar; Kanpur, Uttar Pradesh; Udaipur, Rajasthan; Ranchi, Jharkhand; and Srinagar in the union territory of Jammu and Kashmir. Its core focus is on providing specialized tertiary medical care in Tier 2 and 3 cities, while seeking to strike a balance between providing quality healthcare services and affordability. The company offers several clinical specialties across its hospitals including cardiac sciences, oncology, neuro sciences, gastro sciences and orthopedics and joint replacement. It has established centres of excellence across its hospitals, where it provides clinical specialties and these centres have been instrumental in launching new programs including organ transplant programs. Its extensive 18 years of experience in the healthcare industry in North India has helped the company develop a strong understanding of the region’s market dynamics.
Paras Healthcare IPO Details
Opening Date To be announced |
Closing Date To be announced |
Price Band To be announced |
Issue Size To be Announced |
Face Value ₹1 per share |
Market Lot To be announced |
Listing at NSE,BSE |
Paras Healthcare IPO Timeline (Tentative Schedule)
IPO Open Date | To be announced |
---|---|
IPO Close Date | To be announced |
Allotment Date | To be announced |
Initiation Of Refunds | To be announced |
Credit Of Shares To Demat Account |
To be announced |
IPO Listing Date | To be announced |
UPI Mandate Expiry Date | To be Announced |
Checkout the List of Upcoming IPO
Financial Highlights
Particulars | Total Assets | Total Liabilities | Total Expenses | Total Revenue | Profit after tax | EBITDA |
---|---|---|---|---|---|---|
31 March’24 (In Cr.) | 147.77 | 147.77 | 115.78 | 116.45 | -1.54 | 15.45 |
31 March’23 (In Cr.) | 129.32 | 129.32 | 96.32 | 93.61 | -4.28 | 8.77 |
31 March’22 (In Cr.) | 83.64 | 83.64 | 63.86 | 61.53 | -2.59 | 5.4 |
Strengths & Weakness
Strengths | Weaknesses | ||
---|---|---|---|
Asset light business model with several initiatives to drive patient access and performance. | Business relies on healthcare professionals, and difficulties in attracting, retaining, or training them could harm operations and financial health. | ||
Delivering quality clinical care by attracting and retaining renowned clinicians. | Reliance on North India hospitals, including key revenue centers, makes it vulnerable to regional adverse developments. | ||
Diversified operations across clinical specialties, payor mix and hospitals. | High healthcare costs which can't be passed to patients may impact business and financial health. | ||
Robust operating infrastructure across hospitals including information technology and modern equipment. | Healthcare reforms and uncertain pharmaceutical pricing could impact business and financial health. |
How to apply in IPO via UPI on Dynami
A simple and smartest way to Apply in IPO online via Religare Dynami Mobile App
How to apply for Paras Healthcare IPO?
Retail investors need to apply for the IPO using UPI
UPI
- Link your bank account to a UPI ID.
- Register your UPI id with your Demat account.
- Subscribe for Paras Healthcare IPO and approve the payment on your UPI ID.
Demat Account
- If you are an existing Dynami user, Pre-Apply Now!
- If you’re a new investor, open free demat account with our Dynami App and begin your investment journey.
How to open a
Demat & Trading Account?


Fill up your personal details in the form above


Fill up your DOB, PAN, email & bank account details

Upload your photo and e-sign your application via Aadhaar OTP
Frequently Asked Questions
What is the price band of the IPO?
To be announced
What is the size of the company?
To be announced
What is the minimum lot size of the IPO?
To be announced
What is the minimum investment required?
To be announced
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved. Please note that by submitting your mobile and email on our website, you are authorizing us to Call/SMS/Whtsapp/Email you even though you may be registered under DNC. We shall Call/SMS you for a period of 6 months
Religare Broking Limited (RBL): Registered Office: 2nd Floor, P-14, 45/90, P-Block, Connaught Place, New Delhi 110001. Board line number: 011-49871213. Fax No.: 011-49871189
Religare Broking Limited (CIN: U65999DL2016PLC314319) Registered Office: Religare Broking Limited, 2nd Floor, P-14, 45/90, P-Block, Connaught Place, New Delhi 110001. Board line number: 011-46272400, Fax No. 011-46272447. Member Religare Broking Limited (RBL) : SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235; BSE CM, F&O, CD, CO Code: 3004 Clearing No: 3004; MSE CM, F&O, CD, TM Code: 1051| MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809. Depository Participant : Religare Broking Limited (RBL) – NSDL: DP ID: IN 301774 | SEBI Regn. No: IN-DP-385-2018 | CDSL DP ID: 30200 | SEBI Regn. No: IN-DP-385-2018. Research Analyst: Religare Broking Limited (RBL) – SEBI Regn. No: INH100006977 | Registrars to an issue and share Transfer Agents (RTA) - SEBI Regi. No : INR000004361 | Corporate Agent (Composite) - IRDA Regi. No : CA0581 | National Pension System - Point of Presence (NPS-POP) - PFRDA Regi. No : POP01092018.
Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. RBL is a distributor of Mutual Funds / IPOs / Insurance / Bonds & NCDs. Equities, Currencies & Depository Services are offered through Religare Broking Ltd. Brokerage will not exceed the SEBI prescribed limit. | Securities quoted are exemplary and are not recommendatory. |
https://religareonline.com/disclaimer